# US 2019/0057186 A1 · Methods and compositions for the detection, classification, and diagnosis of schizophrenia

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0057186 A1
- Document ID: US20190057186A1
- Status: Published application
- Kind: A1
- Application number: 16/168,525
- Filed: 2018-10-23
- Published: 2019-02-21
- Earliest claimed: 2014-08-29
- Assignees: Washington University
- Applicants: Washington University
- Inventors: Jorge Sergio Zwir; Claude Robert Cloninger; Francisco Javier Arnedo Fernandez; Dragan Svrakic; Maria Coral del Val Munoz; Gabriel Alejandro de Erausquin
- Web page: https://patentgrep.com/patent/US20190057186A1

## CPC

- G16B 20/20: Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
- C12Q 1/6883: for diseases caused by alterations of genetic material
- G16B 20/00: ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B 30/00: ICT specially adapted for sequence analysis involving nucleotides or amino acids
- C12Q 2600/112: Disease subtyping, staging or classification
- C12Q 2600/156: Polymorphic or mutational markers
- C12Q 2600/158: Expression markers
- C12Q 2600/16: Primer sets for multiplex assays
- G16B 20/30: Detection of binding sites or motifs
- G16B 20/40: Population genetics; Linkage disequilibrium
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Disclosed are compositions and methods for the diagnosis and classification of schizophrenia.

## Claims

### Claim 1

A method of predicting schizophrenia type in a subject having schizophrenia, comprising:
obtaining a biological sample from a subject comprising DNA (e.g., plasma or tissue extracts);
detecting by genome array, low density PCR array or oligo array single nucleotide polymorphisms (SNPs) consisting of 19_2, 88_64, 81_13, 87_76, 58_29, 83_41, 9_9, 10_4, 14_6, 56_30, 42_37, 65_25, 71_55, 12_11, 90_78, 77_5, 88_8, 51_28, 59_48, 41_12, 22_11, 13_12, 31_22, 85_84, 87_84, 16_10, 56_19, 75_31, 81_73, 85_23, 21_8, 76_74, 61_39, 75_67, 76_63, 81_3, 87_26, 88_43, 25_10, 12_2, 52_42, and 54_51; and
assigning the subject to a schizophrenia type selected from (i) severe process, with positive and negative symptom schizophrenia; (ii) positive and negative schizophrenia; (iii) negative schizophrenia; (iv) positive schizophrenia; (v) severe process, positive schizophrenia; (vi) moderate process, disorganized negative schizophrenia; (vii) moderate process, positive and negative schizophrenia; or (viii) moderate process, continuous positive schizophrenia.

### Claim 2 (depends on 1)

The method of claim 1, wherein the one or more SNP sets are selected from the group consisting of 88_8, 90_78, 65_25, 42_37, 71_55, 56_30, 77_5, 12_11, 51_28, 59_48, 10_4, 83_41, 58_29, 9_9, 14_6, 87_76, 88_64, and 81_13.

### Claim 3 (depends on 1)

The method of claim 1, wherein the one or more SNP sets are selected from the group consisting of 10_4, 83_41, 58_29, 9_9, 14_6, 87_76, 88_64, and 81_13.

### Claim 4 (depends on 1)

The method of claim 1, wherein the one or more SNP sets are selected from the group consisting of 87_76, 88_64, and 81_13.

### Claim 5 (depends on 1)

The method of claim 1, wherein the system selects for severe process, with positive and negative symptom schizophrenia, and wherein the one or more SNP sets comprise 56_30, 75_67, or 76_74.

### Claim 6 (depends on 1)

The method of claim 1, wherein the system selects for positive and negative Schizophrenia, and wherein the one or more SNP sets comprise 59_48, 71_55, 21_8, 54_51, 31_22, 65_25, or 87_84.

### Claim 7 (depends on 1)

The method of claim 1, wherein the system selects for negative Schizophrenia, and wherein the one or more SNP sets comprise 58_29, 9_9, 22_11, 81_3, 13_12, 61_39, 10_4, 81_73, 75_31, 56_19, 88_8, or 12_2.

### Claim 8 (depends on 1)

The method of claim 1, wherein the system selects for Positive Schizophrenia, and wherein the one or more SNP sets comprise 88_64, 85_84, or 41_12.

### Claim 9 (depends on 1)

The diagnostic system of claim 1, wherein the system selects for severe process, positive schizophrenia, and wherein the one or more SNP sets comprise 77_5, 81_13, or 25_10.

### Claim 10 (depends on 1)

The method of claim 1, wherein the system selects for moderate process, disorganized negative schizophrenia, and wherein the one or more SNP sets comprise 19_2, 52_42, 90_78, 12_11, 87_76, or 14_6.

### Claim 11 (depends on 1)

The method of claim 1, wherein the system selects for moderate process, positive and negative schizophrenia, and wherein the one or more SNP sets comprise 42_37, 88_43, or 51_28.

### Claim 12 (depends on 1)

The method of claim 1, wherein the system selects for moderate process, continuous positive schizophrenia, and wherein the one or more SNP sets comprise 16_10, 83_41, or 87_26.

### Claim 13 (depends on 1)

The method of claim 1, further comprising one or more phenotype panels, wherein each phenotype panel comprises one or more phenotypic sets selected from the group comprising 15_13, 12_11, 21_1, 50_46, 9_6, 46_23, 54_11, 30_17, 18_13, 27_6, 61_18, 64_11, 65_64, 12_4, 42_9, 52_28, 7_3, 48_41, 26_8, 69_41, 10_5, 17_2, 63_24, 69_66, 22_13, 53_6, 59_41, 20_19, 55_7, 34_17, 27_7, 4_1, 66_54, 8_4, 51_38, 42_7, 18_3, 46_29, 5_2, 57_39, 11_5, 24_4, 48_7, 28_23, or 25_20.

### Claim 14 (depends on 13)

The method of claim 13, wherein the system selects for severe process, with positive and negative symptom schizophrenia, and wherein the one or more phenotypic sets comprise 15_13, 12_11, 21_1, 50_46, 9_6, 46_23, 54_11, 30_17, 18_13, 27_6, 61_18, 64_11, or 65_64.

### Claim 15 (depends on 13)

The method of claim 13, wherein the system selects for positive and negative schizophrenia, and wherein the one or more phenotypic sets comprise 12_4 or 42_9.

### Claim 16 (depends on 14)

The diagnostic system of claim 14, wherein the system selects for negative schizophrenia, and wherein the one or more phenotypic sets comprise 52_28, 7_3, 48_41, 26_8, 69_41, 10_5, or 17_2.

### Claim 17 (depends on 14)

The diagnostic system of claim 14, wherein the system selects for positive schizophrenia, and wherein the one or more phenotypic sets comprise 63_24 and 69_66.

### Claim 18 (depends on 14)

The diagnostic system of claim 14, wherein the system selects for severe process, positive schizophrenia, and wherein the one or more phenotypic sets comprise 22_13, 18_13, 53_6, 59_41, 20_19, 55_7, 34_17, 69_66, 27_7, 18_13, 4_1, 66_54, or 8_4.

### Claim 19 (depends on 13)

The method of claim 13, wherein the system selects for moderate process, disorganized negative schizophrenia, and wherein the one or more phenotypic sets comprise 51_38, 42_7, 18_3, or 46_29.

### Claim 20 (depends on 13)

The method of claim 13, wherein the system selects for moderate process, positive and negative schizophrenia, and wherein the one or more phenotypic sets comprise 5_2, 57_39, 11_5, or 24_4.

### Claim 21 (depends on 13)

The method of claim 13, wherein the system selects for moderate process, continuous positive schizophrenia, and wherein the one or more phenotypic sets comprise 48_7, 28_23, or 25_20.

### Claim 22 (depends on 1)

The method of claim 1, wherein the method further comprises a means for reading the one or more SNP sets, a computer operationally linked to the means for reading the one or more SNP sets, and a display for visualizing the diagnostic risk; wherein the computer identifies the SNP, compares the SNP profile to a control, and catalogs that data, wherein the computer provides an input source for inputting phenotypic data into a phenomic database; wherein the computer compares the SNP and phenotypic data and calculates relationships between the genomic and phenotypic data; wherein the computer compares the genomic and phenotypic relationship data to a reference standard; and wherein the computer outputs the relationship data and the standard on the display.

### Claim 23 (depends on 1)

A method of diagnosing a subject with schizophrenia comprising obtaining a biological sample from the subject, obtaining clinical data from the subject, and applying the biological sample and clinical data to the diagnostic system of claim 1.

### Claim 24

A method of diagnosing a subject with schizophrenia and determining the schizophrenia class comprising: a. obtaining a biological sample from the subject; b. obtaining clinical data from the subject; c. applying the biological sample and clinical data to a diagnostic system for diagnosing schizophrenia, wherein the diagnostic system comprises one or more expression panels and one or more phenotypic panels; d. comparing the genomic and phenotypic panels results to a reference standard; wherein the presence of one or more SNP sets and phenotypic sets in the subjects sample indicates the presence of schizophrenia, and wherein the genomic and phenotypic profile of the reference standard most closely correlating with the subjects genomic and phenotypic profile indicates schizophrenia class of the subject.

### Claim 25 (depends on 23)

The method of claim 23, wherein the one or more expression panels each comprise one or more of the single nucleotide polymorphism (SNP) sets selected from the group comprising 19_2, 88_64, 81_13, 87_76, 58_29, 83_41, 9_9, 10_4, 14_6, 56_30, 42_37, 65_25, 71_55, 12_11, 90_78, 77_5, 88_8, 51_28, 59_48, 41_12, 22_11, 13_12, 31_22, 85_84, 87_84, 16_10, 56_19, 75_31, 81_73, 85_23, 21_8, 76_74, 61_39, 75_67, 76_63, 81_3, 87_26, 88_43, 25_10, 12_2, 52_42, or 54_51.

### Claim 26 (depends on 23)

The method of claim 23, wherein the one or more phenotype panels each comprise one or more phenotypic sets selected from the group comprising 15_13, 12_11, 21_1, 50_46, 9_6, 46_23, 54_11, 30_17, 18_13, 27_6, 61_18, 64_11, 65_64, 12_4, 42_9, 52_28, 7_3, 48_41, 26_8, 69_41, 10_5, 17_2, 63_24, 69_66, 22_13, 53_6, 59_41, 20_19, 55_7, 34_17, 27_7, 4_1, 66_54, 8_4, 51_38, 42_7, 18_3, 46_29, 5_2, 57_39, 11_5, 24_4, 48_7, 28_23, or 25_20.
